COVID-19
Your central place to rapidly access latest news, translated guidance information, and expert interpretations from our former regulators related to COVID-19. Parexel’s 1000+ consulting experts are closely following agency announcements and new guidances and can help provide deep expertise and experience in the race to bring this outbreak to a close. We’re here to fight this with you.
-
View NowCOVID-19 weekly Health Authority updates
Updated every day, in a single source
-
Learn MoreThe Special Approval Pathway (SAP) for COVID-19 related products in China
The regulatory pathway for COVID-19 drugs in China is governed by the Special Approval Program (SAP) which was introduced by National Medical Product Administration (NMPA) in 2005. SAP is...
-
See Parexel's latest COVID-19 expert content
View all -
Learn MoreAgainst All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?
Key Takeaways The COVID-19 pandemic has drawn attention to international efforts to promote...
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup October 26, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Visit Parexel's COVID 19 Clearinghouse
Visit Now -
Learn MoreThe World Health Organization and Wikimedia Foundation expand access to trusted information about COVID-19 on Wikipedia
The World Health Organization (WHO) and the Wikimedia Foundation, the nonprofit that administers Wikipedia, announced today a collaboration to expand the public’s access to the latest and most...
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup October 23, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup October 23, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Learn MoreDrug Development for Rare Disease and Oncology During the COVID-19 Pandemic
-
Learn More
Strengthening global collaboration on COVID-19 real-world evidence and observational studies, , 23/10/2020
Medicines regulators from around the world discussed their experiences with supporting and assessing real-world evidence to facilitate regulatory...
-
Learn More
Nigeria resumes Yellow fever vaccination with safety measures necessary for the COVID-19 context
You can access the original press release by clicking here.
-
Learn More
Lupus Anticoagulant in Patients with Covid-19
New England Journal of Medicine, Ahead of Print.
-
Learn More
Facial Masking for Covid-19
New England Journal of Medicine, Ahead of Print.
-
Learn MoreFDA Approves First Treatment for COVID-19
FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first...
-
Learn MoreFDA’s approval of Veklury (remdesivir) for the treatment of COVID-19—The Science of Safety and Effectiveness
FDA recognizes that patients affected by coronavirus 2019 (COVID-19) are in great need of medicines to treat this disease. To help meet this need, the agency is helping to speed the development of...
-
Learn MoreFDA Approves First Treatment for COVID-19
FDA approved the antiviral drug Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. Veklury is the first...
-
Learn More
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
New England Journal of Medicine, Ahead of Print.
-
Learn More
Covid-19 Vaccine Trials and Incarcerated People — The Ethics of Inclusion
New England Journal of Medicine, Ahead of Print.
-
Learn More
Anticoagulation in Hospitalized Patients with Covid-19
New England Journal of Medicine, Volume 383, Issue 17, Page 1675-1678, October 2020.
-
Learn More
Audio Interview: Tocilizumab and Covid-19
New England Journal of Medicine, Volume 383, Issue 17, October 2020.
-
Learn MoreCoronavirus (COVID-19) Update: Daily Roundup October 20, 2020
Coronavirus (COVID-19) Update: Daily Roundup
-
Loading More...
